Q3 2023 update: virtual care related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that virtual care accounted for 3 pharmaceutical deals announced in Q3…
Analysis of the key themes driving M&A activity reveals that virtual care accounted for 3 pharmaceutical deals announced in Q3…
The global pharmaceutical industry experienced a 32% drop in company filings mentions of virtual care in Q4 2023 compared with…